pharma · Atopic Dermatitis · Seborrheic Keratosis · ACRS
Aclaris Therapeutics
Aclaris Therapeutics patent portfolio — 18 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 170 N Radnor Chester Rd, Radnor Township, Pennsylvania, US
- Founded
- 2012
- Employees
- 10
- Programs
- 33
- Drugs
- 12
- Patents
- 18
Aclaris Therapeutics patents
18 pharmaceutical patents indexed for Aclaris Therapeutics. 0 expire within 24 months.
Aclaris Therapeutics has 18 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12403141
Deuterated MK2 pathway inhibitors and methods of using the same
granted -
US 12370195
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 12297203
Pyrrolopyrimidine ITK inhibitors
granted -
US 12281111
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 11844801
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 11820775
Pyrrolopyrimidine ITK inhibitors
granted -
US 11739086
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 10981906
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted -
US 10800775
Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
granted -
US 10729720
Peroxide formulations and methods and applicators for using the same
granted -
US 10653721
Peroxide formulations and methods and applicators for using the same
granted -
US 10493103
Peroxide formulations and methods and applicators for using the same
granted -
US 10335391
Stabilized oxymetazoline formulations and their uses
granted -
US 10316038
Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancer
granted -
US 10150783
Heterocyclic ITK inhibitors for treating inflammation and cancer
granted -
US 10098910
Peroxide formulations and methods and applicators for using the same
granted -
US 9980983
Peroxide formulations and methods and applicators for using the same
granted -
US 9675639
Peroxide formulations and methods and applicators for using the same
granted
Frequently asked questions
How many patents does Aclaris Therapeutics have?
18 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Aclaris Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.